Skip to content

Physical Activity in Promoting Smoking Cessation in African Americans

Using Physical Activity to Facilitate Smoking Cessation Among African American Adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01915810
Enrollment
45
Registered
2013-08-05
Start date
2014-01-29
Completion date
2027-01-31
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Current Smoker, Healthy Subject

Brief summary

This randomized pilot clinical trial studies the use of physical activity in promoting the discontinuation of the habit of smoking (smoking cessation) in African Americans. Participating in physical activity during an actual smoking quit attempt may work better in helping African Americans stop smoking.

Detailed description

PRIMARY OBJECTIVES: I. Evaluate the feasibility of a Smoking Cessation with Physical Activity (SCwPA) intervention among an African American (AA) church-based sample of adult current smokers. II. Conduct post-intervention focus groups to obtain feedback from pilot participants regarding the acceptability of the SCwPA project design and procedures. III. Examine how physical activity (PA) and the timing of PA initiation affects the mechanisms underlying cessation among an AA church-based sample of adult daily smokers who are attempting to quit. OUTLINE: Participants are randomized to 1 of 3 arms. ARM I (PRE-QUIT PHYSICAL ACTIVITY): Participants receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks. Beginning 2 weeks before the assigned quit date, participants receive a Walking Program guide and engage in the SCwPA comprising brisk, self-paced walking with a goal of 150 minutes of exercise activity per week for 5 weeks. ARM II (QUIT DAY PHYSICAL ACTIVITY): Participants receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks. Beginning on the assigned quit date, participants receive a Walking Program guide and engage in the SCwPA comprising brisk, self-paced walking with a goal of 150 minutes of exercise per week for 5 weeks. ARM III (NO PHYSICAL ACTIVITY): Participants quit smoking on an assigned date and receive telephone-based cessation counseling over 15-20 minutes 1-2 weeks before assigned quit date and nicotine patch for 6 weeks.

Interventions

BEHAVIORALExercise Intervention

Complete SCwPA intervention

OTHERLaboratory Biomarker Analysis

Correlative studies

DRUGNicotine Patch

Receive nicotine patch

OTHERQuestionnaire Administration

Ancillary studies

Receive smoking cessation counseling

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Self-reported African-American race * Current daily smoker (has smoked \>= 100 cigarettes in lifetime per self-report, smoked \>= 5 cigarettes per day for the last 6 months per self-report) * Self-reports motivation to quit smoking within the next 2 weeks * Reports willingness to engage in a physical activity-based smoking cessation intervention * Has a home address and a functioning home and/or cell phone number * Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q) or by physicians clearance (letter from physician or nurse practitioner) if currently taking medication for blood pressure or diabetes * Willingness to wear the nicotine patches provided in the study as recommended * Have an expired carbon monoxide (CO) level \> 8 parts per million (ppm) suggestive of current smoking * Blood pressure =\< 140/90mm or by physicians clearance (letter from physician or nurse practitioner) if blood pressure reading \> 140/90mm Hg

Exclusion criteria

* Contraindication for nicotine patch use * Regular use of tobacco products other than cigarettes in the last 30 days (including black \& milds) * Current or planned future use of any nicotine replacement or pharmacological product for smoking cessation other than the study patches * Pregnancy or lactation * Another household member enrolled in the study * A schedule not accommodating to the study procedures, or unwillingness to adhere to the procedures

Design outcomes

Primary

MeasureTime frameDescription
Recruitment feasibility, defined as >= 75% of eligible/screened participants choose to enroll in the studyUp to 8 weeks
Retention feasibility, defined as an overall retention rate of 80% and if each enrolled participant completes >= 66.7% of study visits (>= 6 of 9 study visits)Up to 8 weeks
Post intervention focus group analysisUp to 8 weeksEach focus group will use a semi-structured interview guide for consistency, which will consist of approximately 15 open-ended questions. If results do not suggest intervention feasibility, post-intervention focus groups will help to identify why feasibility was not achieved. Focus group transcripts will be imported into a qualitative data analysis software program, such as NVivo, to facilitate data retrieval and analysis and to organize data by themes based on phrases, patterns, relationships, and commonalties or disparities.

Secondary

MeasureTime frameDescription
Mechanisms underlying smoking cessation (e.g., stress, positive and negative affect, depression, smoking urges, self-efficacy, motivation, PA enjoyment, and heart rate variability)Up to 8 weeksValidated questionnaires via associated scoring manuals or by convention in the literature will be scored. Descriptive statistics, including mean and variance estimates with 95% confidence intervals, relevant to each of the identified mechanism variables, for each intervention group will be generated. Group\*time effects with regard to stress, positive and negative affect, depression, smoking urges, self-efficacy, motivation, and heart rate variability will be examined using repeated measure analyses of variance as the primary analysis technique.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLorna McNeill

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026